Atossa Therapeutics
ATOS
ATOS
52 hedge funds and large institutions have $20.2M invested in Atossa Therapeutics in 2023 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 10 increasing their positions, 14 reducing their positions, and 3 closing their positions.
Holders
52
Holders Change
+7
Holders Change %
+15.56%
% of All Funds
0.82%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
10
Reduced
14
Closed
3
Calls
$1.38M
Puts
$91K
Net Calls
+$1.29M
Net Calls Change
+$576K
Top Buyers
Top Sellers
| 1 |
1
D.E. Shaw & Co
New York
|
$273K |
| 2 |
2
BlackRock
New York
|
$3.65M |
| 3 |
3
Millennium Management
New York
|
$399K |
| 4 |
4
Geode Capital Management
Boston,
Massachusetts
|
$1.4M |
| 5 |
5
State Street
Boston,
Massachusetts
|
$550K |
